GNH USA

Europe — EMA

Moxonidin Ratiopharm (Moxonidine)

GNH USA supplies Moxonidin Ratiopharm (Moxonidine), an imidazoline receptor agonist for essential hypertension. Request a quote for global supply today.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidin Ratiopharm, is an imidazoline receptor agonist presented as a tablet for oral use. It treats essential hypertension in adult patients.

GNH USA supplies Moxonidin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine is used to manage essential hypertension, a condition characterized by elevated systemic blood pressure.

- Essential hypertension: lowers systolic and diastolic blood pressure, helping to reduce cardiovascular risk.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Dry mouth: reduced salivation leading to a dry sensation. - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headedness, especially when standing quickly. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Bradycardia: unusually slow heart rate. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reaction: rash, itching, swelling, or difficulty breathing.

What precautions apply to Moxonidine?

Before initiating therapy with Moxonidine, consider the following safety measures.

- Blood pressure monitoring: check regularly to avoid excessive hypotension. - Discontinuation: do not stop abruptly; taper under medical supervision. - Renal impairment: adjust use in patients with reduced kidney function. - Hepatic disease: use cautiously in severe liver conditions. - Hypersensitivity: avoid if known allergy to the drug or excipients. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

What does Moxonidine interact with?

Moxonidine can interact with other medicines, affecting blood pressure control or drug levels.

Major Interactions (Avoid): - Other centrally acting antihypertensives (e.g., clonidine): additive hypotensive effect. - Potent CYP2D6 inhibitors (e.g., fluoxetine): may increase plasma concentrations of Moxonidine. - NSAIDs (e.g., ibuprofen): can blunt antihypertensive response.

Moderate Interactions (Monitor Closely): - Diuretics: monitor electrolytes and blood pressure. - Alcohol: may enhance dizziness and hypotension.

Frequently asked questions

What is Moxonidin Ratiopharm used for?+
Moxonidin Ratiopharm contains the active ingredient Moxonidine, which is prescribed to lower high blood pressure in adults with essential hypertension. By reducing systemic vascular resistance, it helps to achieve target blood pressure levels and lower the risk of cardiovascular complications.
How does Moxonidine work?+
Moxonidine acts as a selective agonist at imidazoline I1 receptors in the brainstem. Stimulation of these receptors diminishes sympathetic nervous system activity, leading to reduced heart rate and peripheral vascular resistance, which together lower arterial blood pressure.
What is the usual dose of Moxonidin Ratiopharm?+
The appropriate dose of Moxonidin Ratiopharm is determined by the prescribing healthcare professional based on the individual’s blood pressure, response to therapy, and any co‑existing medical conditions. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Moxonidin Ratiopharm safe during pregnancy or breastfeeding?+
Safety data for Moxonidine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.
How do I order Moxonidin Ratiopharm from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Moxonidine compare with other antihypertensive classes?+
Moxonidine belongs to the imidazoline receptor agonist class, which lowers blood pressure by reducing sympathetic outflow. Unlike beta‑blockers or ACE inhibitors, it does not directly block adrenergic receptors or inhibit the renin‑angiotensin system, offering an alternative mechanism that may be useful when other agents are insufficient or not tolerated.
What are the storage and handling requirements for Moxonidin Ratiopharm?+
Moxonidin Ratiopharm tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date.
How is Moxonidin Ratiopharm administered?+
The medication is taken orally, usually once daily with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush, chew, or split the tablet unless specifically instructed.
What are the most serious risks associated with Moxonidine?+
Serious adverse events, although rare, include severe hypotension, bradycardia, significant liver enzyme elevations, and allergic reactions such as rash, swelling or breathing difficulty. Patients should seek immediate medical attention if any of these symptoms occur.
Who should not use Moxonidin Ratiopharm?+
Moxonidin Ratiopharm is contraindicated in individuals with known hypersensitivity to Moxonidine or any tablet excipients. Caution is also advised for patients with severe hepatic impairment, uncontrolled heart failure, or those taking other centrally acting antihypertensives without close monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Teva Gyógyszergyár Zrt
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU